Skip to main content
. 2012 Aug;56(8):4223–4232. doi: 10.1128/AAC.06253-11

Fig 1.

Fig 1

Schematic representation of the ergosterol biosynthetic pathway in C. glabrata showing the structure of sterols used in the present study. (A) Classical pathway; (B) sterol intermediates that accumulate following azole inhibition of sterol 14α-demethylase (ERG11 protein); (C) end product ergosterol, the binding target of polyene antifungals; (D) cholesterol and related sterol intermediates.